Recruitment of factor H as a novel complement evasion strategy for blood-stage plasmodium falciparum infection

Journal of Immunology

Volumn 196, Issue 3, 2016, Pages 1239-1248

  Kennedy, Alexander T ^a,b   Schmidt, Christoph Q ^c   Thompson, Jennifer K ^a   Weiss, Greta E ^d   Taechalertpaisarn, Tana ^d   Gilson, Paul R ^d,e   Barlow, Paul N ^f   Crabb, Brendan S ^b,d,e   Cowman, Alan F ^a,b   Tham, Wai Hong ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF ULM   (Germany)

^d BURNET INSTITUTE   (Australia)

^e MONASH UNIVERSITY   (Australia)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COAT PROTEIN; COMPLEMENT FACTOR; COMPLEMENT FACTOR H; FACTOR H LIKE 1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; IMMUNE EVASION; MALARIA FALCIPARUM; MEROZOITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PROTEIN INTERACTION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; IMMUNOPRECIPITATION; WESTERN BLOTTING;

BLOTTING, WESTERN; COMPLEMENT ACTIVATION; COMPLEMENT FACTOR H; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNE EVASION; IMMUNOPRECIPITATION; MALARIA, FALCIPARUM; MEROZOITES;

EID: 84957648504     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501581     Document Type: Article

References (52)

1. WHO. 2012. World Malaria Report: 2012. World Health Organisation, Geneva, Switzerland.
2. Boyle, M. J., D. W. Wilson, J. S. Richards, D. T. Riglar, K. K. A. Tetteh, D. J. Conway, S. A. Ralph, J. Baum, and J. G. Beeson. 2010. Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development. Proc. Natl. Acad. Sci. USA 107: 14378-14383.
3. Frank, M. M., and L. F. Fries. 1991. The role of complement in inflammation and phagocytosis. Immunol. Today 12: 322-326.
4. Walport, M. J. 2001. Complement. First of two parts. N. Engl. J. Med. 344: 1058-1066.
5. Ricklin, D., G. Hajishengallis, K. Yang, and J. D. Lambris. 2010. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11: 785-797.
6. Zipfel, P. F., M. Mihlan, and C. Skerka. 2007. The alternative pathway of complement: a pattern recognition system. Adv. Exp. Med. Biol. 598: 80-92.
7. Janssen, B. J. C., and P. Gros. 2007. Structural insights into the central complement component C3. Mol. Immunol. 44: 3-10.
8. Zipfel, P. F., and C. Skerka. 2009. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 9: 729-740.
9. Schmidt, C. Q., A. P. Herbert, H. G. Hocking, D. Uhŕin, and P. N. Barlow. 2008. Translational mini-review series on complement factor H: structural and functional correlations for factor H. Clin. Exp. Immunol. 151: 14-24.
10. Ferreira, V. P., A. P. Herbert, H. G. Hocking, P. N. Barlow, and M. K. Pangburn. 2006. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J. Immunol. 177: 6308-6316.
11. Józsi, M., M. Oppermann, J. D. Lambris, and P. F. Zipfel. 2007. The C-terminus of complement factor H is essential for host cell protection. Mol. Immunol. 44: 2697-2706.
12. Meri, S., and M. K. Pangburn. 1990. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA 87: 3982-3986.
13. Schmidt, C. Q., A. P. Herbert, D. Kavanagh, C. Gandy, C. J. Fenton, B. S. Blaum, M. Lyon, D. Uhrín, and P. N. Barlow. 2008. A new map of glycosaminoglycan and C3b binding sites on factor H. J. Immunol. 181: 2610-2619.
14. Kajander, T., M. J. Lehtinen, S. Hyvärinen, A. Bhattacharjee, E. Leung, D. E. Isenman, S. Meri, A. Goldman, and T. S. Jokiranta. 2011. Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement. Proc. Natl. Acad. Sci. USA 108: 2897-2902.
15. Morgan, H. P., C. Q. Schmidt, M. Guariento, B. S. Blaum, D. Gillespie, A. P. Herbert, D. Kavanagh, H. D. T. Mertens, D. I. Svergun, C. M. Johansson, et al. 2011. Structural basis for engagement by complement factor H of C3b on a self surface. Nat. Struct. Mol. Biol. 18: 463-470.
16. Clark, S. J., C. Q. Schmidt, A. M. White, S. Hakobyan, B. P. Morgan, and P. N. Bishop. 2014. Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related mac-ular degeneration. J. Immunol. 193: 4962-4970.
17. Sofat, R., P. P. Mangione, J. R. Gallimore, S. Hakobyan, T. R. Hughes, T. Shah, T. Goodship, F. D'Aiuto, C. Langenberg, N. Wareham, et al. 2013. Distribution and determinants of circulating complement factor H concentration determined by a high-throughput immunonephelometric assay. J. Immunol. Methods 390: 63-73.
18. Lambris, J. D., D. Ricklin, and B. V. Geisbrecht. 2008. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6: 132-142.
19. Granoff, D. M., J. A. Welsch, and S. Ram. 2009. Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera. Infect. Immun. 77: 764-769.
20. Schneider, M. C., B. E. Prosser, J. J. E. Caesar, E. Kugelberg, S. Li, Q. Zhang, S. Quoraishi, J. E. Lovett, J. E. Deane, R. B. Sim, et al. 2009. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 458: 890-893.
21. Kraiczy, P., C. Skerka, M. Kirschfink, V. Brade, and P. F. Zipfel. 2001. Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H. Eur. J. Immunol. 31: 1674-1684.
22. Lucidarme, J., L. Tan, R. M. Exley, J. Findlow, R. Borrow, and C. M. Tang. 2011. Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein. Clin. Vaccine Immunol. 18: 1002-1014.
23. Maruvada, R., A. M. Blom, and N. V. Prasadarao. 2008. Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells. Immunology 124: 265-276.
24. Cowman, A. F., D. Berry, and J. Baum. 2012. The cellular and molecular basis for malaria parasite invasion of the human red blood cell. J. Cell Biol. 198: 961-971.
25. Healer, J., D. McGuinness, P. Hopcroft, S. Haley, R. Carter, and E. Riley. 1997. Complement-mediated lysis of Plasmodium falciparum gametes by malariaimmune human sera is associated with antibodies to the gamete surface antigen Pfs230. Infect. Immun. 65: 3017-3023.
26. Molina-Cruz, A., L. S. Garver, A. Alabaster, L. Bangiolo, A. Haile, J. Winikor, C. Ortega, B. C. L. van Schaijk, R. W. Sauerwein, E. Taylor-Salmon, and C. Barillas-Mury. 2013. The human malaria parasite Pfs47 gene mediates evasion of the mosquito immune system. Science 340: 984-987.
27. Gerloff, D. L., A. Creasey, S. Maslau, and R. Carter. 2005. Structural models for the protein family characterized by gamete surface protein Pfs230 of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 102: 13598-13603.
28. Punta, M., P. C. Coggill, R. Y. Eberhardt, J. Mistry, J. Tate, C. Boursnell, N. Pang, K. Forslund, G. Ceric, J. Clements, et al. 2012. The Pfam protein families database. Nucleic Acids Res. 40: D290-D301.
29. Williamson, K. C., M. D. Criscio, and D. C. Kaslow. 1993. Cloning and ex-pression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230. Mol. Biochem. Parasitol. 58: 355-358.
30. Gilson, P. R., T. Nebl, D. Vukcevic, R. L. Moritz, T. Sargeant, T. P. Speed, L. Schofield, and B. S. Crabb. 2006. Identification and stoichiometry of glycosylphosphatidylinositol - Anchored membrane proteins of the human malaria parasite Plasmodium falciparum. Mol. Cell. Proteomics 5: 1286-1299.
31. Sanders, P. R., P. R. Gilson, G. T. Cantin, D. C. Greenbaum, T. Nebl, D. J. Carucci, M. J. McConville, L. Schofield, A. N. Hodder, J. R. Yates III, and B. S. Crabb. 2005. Distinct protein classes including novel merozoite surface antigens in Raft-like membranes of Plasmodium falciparum. J. Biol. Chem. 280: 40169-40176.
32. Sanders, P. R., G. T. Cantin, D. C. Greenbaum, P. R. Gilson, T. Nebl, R. L. Moritz, J. R. Yates III, A. N. Hodder, and B. S. Crabb. 2007. Identification of protein complexes in detergent-resistant membranes of Plasmodium falciparum schiz-onts. Mol. Biochem. Parasitol. 154: 148-157.
33. Taechalertpaisarn, T., C. Crosnier, S. J. Bartholdson, A. N. Hodder, J. Thompson, L. Y. Bustamante, D. W. Wilson, P. R. Sanders, G. J. Wright, J. C. Rayner, et al. 2012. Biochemical and functional analysis of two Plasmodium falciparum blood-stage 6-cys proteins: P12 and P41. PLoS One 7: e41937.
34. Rosa, T. F. A., A. Flammersfeld, C. J. Ngwa, M. Kiesow, R. Fischer, P. F. Zipfel, C. Skerka, and G. Pradel. 2015. The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement. Cell. Microbiol. DOI: 10.1111/cmi.12535.
35. Simon, N., E. Lasonder, M. Scheuermayer, A. Kuehn, S. Tews, R. Fischer, P. F. Zipfel, C. Skerka, and G. Pradel. 2013. Malaria parasites co-opt human factor H to prevent complement-mediated lysis in the mosquito midgut. Cell Host Microbe 13: 29-41.
36. Dasari, P., K. Reiss, K. Lingelbach, S. Baumeister, R. Lucius, R. Udomsangpetch, S. C. Bhakdi, and S. Bhakdi. 2011. Digestive vacuoles of Plasmodium falciparum are selectively phagocytosed by and impair killing function of polymorpho-nuclear leukocytes. Blood 118: 4946-4956.
37. Dasari, P., S. D. Heber, M. Beisele, M. Torzewski, K. Reifenberg, C. Orning, A. Fries, A. L. Zapf, S. Baumeister, K. Lingelbach, et al. 2012. Digestive vacuole of Plasmodium falciparum released during erythrocyte rupture dually activates complement and coagulation. Blood 119: 4301-4310.
38. Dasari, P., A. Fries, S. D. Heber, A. Salama, I.-W. Blau, K. Lingelbach, S. C. Bhakdi, R. Udomsangpetch, M. Torzewski, K. Reiss, and S. Bhakdi. 2014. Malarial anemia: digestive vacuole of Plasmodium falciparum mediates complement deposition on bystander cells to provoke hemophagocytosis. Med. Microbiol. Immunol. 203: 383-393.
39. Wilson, D. W., B. S. Crabb, and J. G. Beeson. 2010. Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays. Malar. J. 9: 152.
40. Schmidt, C. Q., F. C. Slingsby, A. Richards, and P. N. Barlow. 2011. Production of biologically active complement factor H in therapeutically useful quantities. Protein Expr. Purif. 76: 254-263.
41. Riglar, D. T., and J. Baum. 2013. Static and dynamic imaging of erythrocyte invasion and early intra-erythrocytic development in Plasmodium falciparum. Methods Mol. Biol. 923: 269-280.
42. Hill, D. L., E. M. Eriksson, A. B. Carmagnac, D. W. Wilson, A. F. Cowman, D. S. Hansen, and L. Schofield. 2012. Efficient measurement of opsonising an-tibodies to Plasmodium falciparum merozoites. PLoS One 7: e51692.
43. Makler, M. T., and D. J. Hinrichs. 1993. Measurement of the lactate dehydro-genase activity of Plasmodium falciparum as an assessment of parasitemia. Am. J. Trop. Med. Hyg. 48: 205-210.
44. Sakamoto, H., S. Takeo, A. G. Maier, J. Sattabongkot, A. F. Cowman, and T. Tsuboi. 2012. Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes. Vaccine 30: 1972-1980.
45. Makou, E., A. P. Herbert, and P. N. Barlow. 2013. Functional anatomy of complement factor H. Biochemistry 52: 3949-3962.
46. Korotaevskiy, A. A., L. G. Hanin, and M. A. Khanin. 2009. Non-linear dynamics of the complement system activation. Math. Biosci. 222: 127-143.
47. Meri, T., H. Amdahl, M. J. Lehtinen, S. Hyvärinen, J. V. McDowell, A. Bhattacharjee, S. Meri, R. Marconi, A. Goldman, and T. S. Jokiranta. 2013. Microbes bind complement inhibitor factor H via a common site. PLoS Pathog. 9: e1003308.
48. Read, D., A. H. Lensen, S. Begarnie, S. Haley, A. Raza, and R. Carter. 1994. Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing. Parasite Immunol. 16: 511-519.
49. Williamson, K. C., D. B. Keister, O. Muratova, and D. C. Kaslow. 1995. Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes. Mol. Biochem. Parasitol. 75: 33-42.
50. Spadafora, C., G. A. Awandare, K. M. Kopydlowski, J. Czege, J. K. Moch, R. W. Finberg, G. C. Tsokos, and J. A. Stoute. 2010. Complement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparum. PLoS Pathog. 6: e1000968.
51. Tham, W.-H., D. W. Wilson, S. Lopaticki, C. Q. Schmidt, P. B. Tetteh-Quarcoo, P. N. Barlow, D. Richard, J. E. Corbin, J. G. Beeson, and A. F. Cowman. 2010. Complement receptor 1 is the host erythrocyte receptor for Plasmodium falci-parum PfRh4 invasion ligand. Proc. Natl. Acad. Sci. USA 107: 17327-17332.
52. Tham, W.-H., C. Q. Schmidt, R. E. Hauhart, M. Guariento, P. B. Tetteh-Quarcoo, S. Lopaticki, J. P. Atkinson, P. N. Barlow, and A. F. Cowman. 2011. Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes. Blood 118: 1923-1933.